MCL coexpression mm9:2396
From FANTOM5_SSTAR
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr4:129419477..129419512,- | p2@Khdrbs1 |
Mm9::chr6:29998062..29998078,+ | p2@Nrf1 |
Mm9::chr8:108160490..108160512,+ | p2@Ctcf |
Mm9::chrX:98469402..98469427,+ | p3@Med12 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0006355 | regulation of transcription, DNA-dependent | 0.00264962671142477 |
GO:0006351 | transcription, DNA-dependent | 0.00264962671142477 |
GO:0032774 | RNA biosynthetic process | 0.00264962671142477 |
GO:0045449 | regulation of transcription | 0.00264962671142477 |
GO:0019219 | regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.00264962671142477 |
GO:0006350 | transcription | 0.00264962671142477 |
GO:0010468 | regulation of gene expression | 0.00264962671142477 |
GO:0031323 | regulation of cellular metabolic process | 0.00264962671142477 |
GO:0019222 | regulation of metabolic process | 0.00264962671142477 |
GO:0016070 | RNA metabolic process | 0.00264962671142477 |
GO:0046831 | regulation of RNA export from nucleus | 0.00264962671142477 |
GO:0010467 | gene expression | 0.00493676572862241 |
GO:0003676 | nucleic acid binding | 0.00501317796555137 |
GO:0010216 | maintenance of DNA methylation | 0.00586084345170822 |
GO:0006139 | nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.00586084345170822 |
GO:0050794 | regulation of cellular process | 0.00726818264355437 |
GO:0003918 | DNA topoisomerase (ATP-hydrolyzing) activity | 0.00856950403349945 |
GO:0050789 | regulation of biological process | 0.00994081576642363 |
GO:0006349 | genetic imprinting | 0.010196033647745 |
GO:0009048 | dosage compensation, by inactivation of X chromosome | 0.010196033647745 |
GO:0003916 | DNA topoisomerase activity | 0.0109891901210296 |
GO:0006265 | DNA topological change | 0.0109891901210296 |
GO:0007549 | dosage compensation | 0.0109891901210296 |
GO:0065007 | biological regulation | 0.0109891901210296 |
GO:0005634 | nucleus | 0.0114538221230214 |
GO:0043283 | biopolymer metabolic process | 0.0124452804732688 |
GO:0046822 | regulation of nucleocytoplasmic transport | 0.0129420245574463 |
GO:0005070 | SH3/SH2 adaptor activity | 0.0140866333941102 |
GO:0006305 | DNA alkylation | 0.0140866333941102 |
GO:0006405 | RNA export from nucleus | 0.0140866333941102 |
GO:0006306 | DNA methylation | 0.0140866333941102 |
GO:0003677 | DNA binding | 0.0158713381875643 |
GO:0006304 | DNA modification | 0.0158755623720686 |
GO:0005515 | protein binding | 0.0174588127541724 |
GO:0000119 | mediator complex | 0.0174588127541724 |
GO:0051168 | nuclear export | 0.0185873464027477 |
GO:0030674 | protein binding, bridging | 0.0196543615796995 |
GO:0006259 | DNA metabolic process | 0.0223176074557033 |
GO:0043170 | macromolecule metabolic process | 0.0247191938869611 |
GO:0007049 | cell cycle | 0.0275956870726719 |
GO:0043414 | biopolymer methylation | 0.0297006816389028 |
GO:0040029 | regulation of gene expression, epigenetic | 0.0297006816389028 |
GO:0060090 | molecular adaptor activity | 0.0297006816389028 |
GO:0032259 | methylation | 0.0297006816389028 |
GO:0050658 | RNA transport | 0.0301391412602402 |
GO:0051236 | establishment of RNA localization | 0.0301391412602402 |
GO:0016591 | DNA-directed RNA polymerase II, holoenzyme | 0.0301391412602402 |
GO:0050657 | nucleic acid transport | 0.0301391412602402 |
GO:0006403 | RNA localization | 0.0301391412602402 |
GO:0048523 | negative regulation of cellular process | 0.0301391412602402 |
GO:0015931 | nucleobase, nucleoside, nucleotide and nucleic acid transport | 0.0312926256970316 |
GO:0044238 | primary metabolic process | 0.0318401864703 |
GO:0048519 | negative regulation of biological process | 0.0318401864703 |
GO:0044237 | cellular metabolic process | 0.0318401864703 |
GO:0043231 | intracellular membrane-bound organelle | 0.0318401864703 |
GO:0043227 | membrane-bound organelle | 0.0318401864703 |
GO:0003713 | transcription coactivator activity | 0.0345795460137525 |
GO:0006730 | one-carbon compound metabolic process | 0.0384526715069959 |
GO:0051049 | regulation of transport | 0.0412136454567188 |
GO:0006913 | nucleocytoplasmic transport | 0.0441006895042575 |
GO:0051169 | nuclear transport | 0.0441006895042575 |
GO:0043229 | intracellular organelle | 0.0464795240315621 |
GO:0043226 | organelle | 0.0464795240315621 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
lymphocyte | 7.80e-07 | 13 |
common lymphoid progenitor | 7.80e-07 | 13 |
Ontology term | p-value | n |
---|---|---|
anterior region of body | 5.78e-12 | 43 |
hemopoietic organ | 4.80e-10 | 29 |
immune organ | 4.80e-10 | 29 |
craniocervical region | 5.24e-10 | 36 |
thymus | 2.60e-08 | 23 |
neck | 2.60e-08 | 23 |
respiratory system epithelium | 2.60e-08 | 23 |
hemolymphoid system gland | 2.60e-08 | 23 |
pharyngeal epithelium | 2.60e-08 | 23 |
thymic region | 2.60e-08 | 23 |
pharyngeal gland | 2.60e-08 | 23 |
entire pharyngeal arch endoderm | 2.60e-08 | 23 |
thymus primordium | 2.60e-08 | 23 |
early pharyngeal endoderm | 2.60e-08 | 23 |
gland of gut | 7.59e-08 | 24 |
pharynx | 1.31e-07 | 24 |
upper respiratory tract | 1.31e-07 | 24 |
chordate pharynx | 1.31e-07 | 24 |
pharyngeal arch system | 1.31e-07 | 24 |
pharyngeal region of foregut | 1.31e-07 | 24 |
respiratory tract | 3.32e-07 | 41 |
mixed endoderm/mesoderm-derived structure | 3.38e-07 | 35 |
respiratory system | 6.10e-07 | 42 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |